What drug interactions and precautions should be considered when prescribing cyclobenzaprine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Cyclobenzaprine Drug Interactions

Cyclobenzaprine is absolutely contraindicated with MAO inhibitors due to life-threatening risk of serotonin syndrome, and requires extreme caution with any serotonergic drugs including SSRIs, SNRIs, TCAs, tramadol, bupropion, meperidine, and verapamil. 1

Critical Contraindications

MAO Inhibitors (Absolute Contraindication)

  • Never combine cyclobenzaprine with MAO inhibitors (phenelzine, isocarboxazid, moclobemide, isoniazid, linezolid)
  • This combination may cause life-threatening interactions 1
  • The mechanism involves cyclobenzaprine's structural similarity to tricyclic antidepressants and its serotonergic activity 2

High-Risk Drug Interactions Requiring Careful Monitoring

Serotonergic Drugs (Risk of Serotonin Syndrome)

Postmarketing surveillance has documented serotonin syndrome cases when cyclobenzaprine is combined with:

  • SSRIs (fluoxetine, sertraline, paroxetine, citalopram, escitalopram)
  • SNRIs (duloxetine, venlafaxine)
  • Tricyclic antidepressants
  • Tramadol
  • Bupropion
  • Meperidine
  • Verapamil 1

If concomitant use is clinically necessary, start the second serotonergic drug at low dose, increase slowly, and monitor intensively during the first 24-48 hours after any dose change 3. Watch for mental status changes (confusion, agitation), neuromuscular hyperactivity (tremors, clonus, hyperreflexia), and autonomic instability (hypertension, tachycardia, diaphoresis) 3.

CNS Depressants (Additive Sedation)

Cyclobenzaprine enhances the effects of:

  • Alcohol
  • Barbiturates
  • Benzodiazepines
  • Opioids
  • Other CNS depressants 1

This combination significantly impairs mental and physical abilities required for operating machinery or driving 1. The 2019 AGS Beers Criteria specifically warns against combining three or more CNS agents (including cyclobenzaprine) due to increased fall risk in older adults 4.

Sedatives and Anesthetic Agents

Cyclobenzaprine has potential to interact with sedatives and anesthetic agents during the perioperative period 2. The 2021 SPAQI consensus recommends holding cyclobenzaprine on the day of operation 2.

Moderate-Risk Interactions

Anticholinergic Medications

Due to cyclobenzaprine's atropine-like action, use with caution in patients taking other anticholinergic medications. This can cause additive anticholinergic effects including:

  • Hallucinations
  • Confusion
  • Drowsiness
  • Constipation
  • Urinary retention
  • Dry mouth 2, 1

Antihypertensive Agents

Cyclobenzaprine (as a tricyclic-related compound) may block the antihypertensive action of guanethidine and similarly acting compounds 1.

Tramadol (Dual Risk)

Tramadol presents a double hazard with cyclobenzaprine:

  1. Increased seizure risk (tricyclic effect)
  2. Serotonin syndrome risk (serotonergic effect) 1

Special Population Considerations

Elderly Patients

  • Start with 5 mg dose and titrate slowly upward 1
  • Plasma concentrations are twice as high in elderly compared to young adults 1
  • Higher risk for CNS adverse events (hallucinations, confusion), cardiac events, falls, and drug-drug interactions 1
  • The 2019 AGS Beers Criteria lists cyclobenzaprine among medications to use with caution in older adults 4

Hepatic Impairment

  • Use with caution in mild hepatic impairment: start 5 mg and titrate slowly 1
  • Avoid in moderate to severe hepatic impairment due to lack of data 1
  • Plasma concentrations are up to twofold higher in mild hepatic insufficiency 5

Specific Medical Conditions Requiring Caution

  • Urinary retention history
  • Angle-closure glaucoma
  • Increased intraocular pressure 1

Perioperative Management

Hold cyclobenzaprine on the day of surgery 2. For long-term users, taper over 2-3 weeks if time permits to prevent withdrawal symptoms (malaise, nausea, headache lasting 2-4 days), though these are not life-threatening 2.

Clinical Monitoring Recommendations

When prescribing cyclobenzaprine:

  1. Screen for MAO inhibitor use (absolute contraindication)
  2. Identify all serotonergic medications and assess risk-benefit
  3. Document CNS depressants (alcohol, benzodiazepines, opioids)
  4. Assess hepatic function and adjust dosing accordingly
  5. Evaluate fall risk, especially in elderly patients
  6. Counsel patients on impaired ability to drive or operate machinery
  7. Monitor for serotonin syndrome signs within 24-48 hours of initiation or dose changes

Common Pitfalls to Avoid

  • Do not assume cyclobenzaprine is "just a muscle relaxant" - it has significant tricyclic antidepressant-like properties and serotonergic activity
  • Do not overlook over-the-counter serotonergic agents (St. John's wort, dextromethorphan, L-tryptophan) 3
  • Do not use standard adult doses in elderly patients - always start at 5 mg 1
  • Do not combine with multiple CNS depressants without careful risk assessment
  • Do not prescribe without checking for MAO inhibitor use within the past 14 days

References

3
Guideline

clinical practice guideline for the assessment and treatment of children and adolescents with anxiety disorders.

Journal of the American Academy of Child and Adolescent Psychiatry, 2020

Related Questions

How should cyclobenzaprine be dosed for an adult with acute low‑back muscle spasm, and what dose adjustments are recommended for patients over 65 or with hepatic/renal impairment?
Should I be concerned about prescribing cyclobenzaprine (muscle relaxant) or prednisone (corticosteroid) to a patient who is taking lisdexamfetamine (Vyvanse) and venlafaxine (Effexor)?
Can cyclobenzaprine cause serotonin syndrome?
Can cyclobenzaprine be stopped abruptly?
Can a patient take Flexeril (cyclobenzaprine) while she is taking trazodone?
How should I manage elevated blood pressure in a patient taking methylphenidate (Ritalin) 10 mg three times daily and bupropion XL (Wellbutrin) 150 mg once daily?
What is the appropriate management for a patient with a favorable lipid panel but an elevated lipoprotein(a) of 98 mg/dL?
What is the appropriate management for an iatrogenic headache?
Can mirtazapine be used to treat aripiprazole (Abilify)-induced akathisia, and what is its mechanism of action?
A patient taking prazosin 1 mg at bedtime, aripiprazole 15 mg daily, and sertraline 100 mg daily reports worsening racing thoughts and insomnia with frequent nocturnal awakenings; what is the next step in management?
What is the optimal COPD treatment for an elderly patient who cannot tolerate Breztri (beclomethasone/formoterol) or Trelegy (fluticasone furoate/umeclidinium/vilanterol) due to a urinary tract infection?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.